(lp0
S"Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial ... GlobeNewswire  - 11 hours ago BERKELEY HEIGHTS, N.J., March 28, 2017  -- Cyclacel Pharmaceuticals, Inc.    a biopharmaceutical company developing oral therapies that target the various phases&nbsp;...Cyclacel Pharmaceuticals, Inc. : Analysts bet a 92.31 percent ... - Post AnalystCyclacel Pharmaceuticals'  CEO Spiro Rombotis on Q4 2016 Results ... - Seeking Alpha"
p1
aS'Cyclacel Pharmaceuticals: Is There Anything Left In The Tank? Seeking Alpha - Mar 9, 2017 Cyclacel Pharmaceuticals Inc.,  is a small biopharmaceutical company that works on developing oral therapies for the treatment of various cancers and diseases with high unmet medical need.Cyclacel Pharmaceuticals, Inc.  Rises on Publication of Data - StockNewsUnionAnalyst Hints Surrounding Cyclacel Pharmaceuticals, Inc.  - Post Analyst'
p2
aS"Guess Who Cyclacel Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 28, 2017 For those not familiar with the company, Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology.Cyclacel Pharmaceuticals Inc  Upgraded to Buy at Zacks Investment Research - The Cerbat GemCyclacel Pharmaceuticals, Inc.'s  stock price is Worth at $3.42 - Hot Stocks Point"
p3
aS'Cyclacel Pharmaceuticals Inc. CYCC  Wall Street Journal - Feb 11, 2011 Cyclacel Pharmaceuticals Inc. CYCC . search. View All companies. AT CLOSE 3:59 PM EDT 03/24/17. $3.42 USD; 0.24 7.55%.'
p4
aS"Cyclacel Pharmaceuticals, Inc.'s  CEO Spiro Rombotis on Q2 2016 Results ... Seeking Alpha - Aug 10, 2016 Good afternoon and welcome to the Cyclacel Pharmaceutical's Second Quarter 2016 Results Conference Call and Webcast. Today's call is being recorded."
p5
aS"Cyclacel's Date With Decitabine Seeking Alpha - Aug 22, 2016 Cyclacel's  long-suffering shareholders will shortly see the outcome of its seemingly endless, so-called Seamless trial of sapacitabine in elderly patients with newly diagnosed acute myeloid leukaemia, after the study finally reached the&nbsp;..."
p6
aS"Cyclacel Pharmaceuticals Inc  Spikes On Tang Capital Stake Schaeffers Research  - Aug 22, 2016 After being halted earlier, Cyclacel Pharmaceuticals Inc  was last seen up 36% at $9.50. Boosting the biotech stock is a recent Securities and Exchange Commission  filing which showed Tang Capital Partners LP took a 9.6% stake in CYCC&nbsp;...Cyclacel Pharmaceuticals Inc : Don't Believe the Hype - Investorplace.comHere's Why Cyclacel Pharmaceuticals  Stock Is Surging Today - TheStreet.com"
p7
aS"Cyclacel Pharmaceuticals: The Devil's Advocate Be Damned Seeking Alpha - Jun 4, 2014 Cyclacel Pharmaceuticals Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it will webcast an invitation-only&nbsp;..."
p8
aS"Here's Why Cyclacel Pharmaceuticals Inc  Could Have A Rough December Market Exclusive - Nov 18, 2016 Cyclacel Pharmaceuticals Inc  soared throughout the US session on Thursday, gaining as much as 60% across the day."
p9
aS'CYCLACEL PHARMACEUTICALS, INC.  Files An 8-K Other Events Market Exclusive - Feb 23, 2017 Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase  inhibitors, polo-like ...Boston Scientific, Ocwen Financial, Cyclacel Pharmaceuticals Stocks Moving Today - Schaeffers Research '
p10
a.